BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16540075)

  • 1. A versatile method of identifying specific binding proteins on affinity resins.
    Yamamoto K; Yamazaki A; Takeuchi M; Tanaka A
    Anal Biochem; 2006 May; 352(1):15-23. PubMed ID: 16540075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the specific binding proteins of bioactive small compound using affinity resins.
    Tanaka A
    Methods Mol Biol; 2009; 577():181-95. PubMed ID: 19718517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative analysis and chemical approach for the reduction of nonspecific binding proteins on affinity resins.
    Tamura T; Terada T; Tanaka A
    Bioconjug Chem; 2003; 14(6):1222-30. PubMed ID: 14624639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolating the whole complex of target proteins of FK506 using affinity resins from novel solid phases.
    Takahashi T; Shiyama T; Mori T; Hosoya K; Tanaka A
    Anal Bioanal Chem; 2006 May; 385(1):122-7. PubMed ID: 16601955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel hydrophilic spacers for the reduction of nonspecific binding proteins on affinity resins.
    Shiyama T; Furuya M; Yamazaki A; Terada T; Tanaka A
    Bioorg Med Chem; 2004 Jun; 12(11):2831-41. PubMed ID: 15142543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective elution of target protein from affinity resins by a simple reductant with a thiol group.
    Mabuchi M; Haramura M; Shimizu T; Nishizaki T; Tanaka A
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7361-4. PubMed ID: 21067925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective ligand purification using high-performance affinity beads.
    Ohtsu Y; Ohba R; Imamura Y; Kobayashi M; Hatori H; Zenkoh T; Hatakeyama M; Manabe T; Hino M; Yamaguchi Y; Kataoka K; Kawaguchi H; Watanabe H; Handa H
    Anal Biochem; 2005 Mar; 338(2):245-52. PubMed ID: 15745744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity labeling the dopamine transporter ligand binding site.
    Vaughan RA; Parnas ML; Gaffaney JD; Lowe MJ; Wirtz S; Pham A; Reed B; Dutta SM; Murray KK; Justice JB
    J Neurosci Methods; 2005 Apr; 143(1):33-40. PubMed ID: 15763134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of monolithic solid material by utilization of spacer for identification of the target using affinity resins.
    Iwaoka E; Mori T; Shimizu T; Hosoya K; Tanaka A
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1469-72. PubMed ID: 19201607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification of specific binding protein using affinity resins for discovery of drug target].
    Tanaka A
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1576-81. PubMed ID: 21089591
    [No Abstract]   [Full Text] [Related]  

  • 11. Affinity chromatography: general methods.
    Urh M; Simpson D; Zhao K
    Methods Enzymol; 2009; 463():417-38. PubMed ID: 19892186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of surface properties of affinity resin for capturing a target protein, cyclooxygenase-1.
    Mori T; Kubo T; Kaya K; Hosoya K
    Bioorg Med Chem; 2009 Feb; 17(4):1587-99. PubMed ID: 19167894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of chemically stable solid phases for the target isolation with reduced nonspecific binding proteins.
    Takahashi T; Shiyama T; Hosoya K; Tanaka A
    Bioorg Med Chem Lett; 2006 Jan; 16(2):447-50. PubMed ID: 16290149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An easy preparation of 'monolithic type' hydrophilic solid phase: capability for affinity resin to isolate target proteins.
    Mori T; Takahashi T; Shiyama T; Tanaka A; Hira N; Tanaka N; Hosoya K
    Bioorg Med Chem; 2006 Aug; 14(16):5549-54. PubMed ID: 16682207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of small molecule binding molecules by affinity purification using a specific ligand immobilized on PEGA resin.
    Kuramochi K; Miyano Y; Enomoto Y; Takeuchi R; Ishi K; Takakusagi Y; Saitoh T; Fukudome K; Manita D; Takeda Y; Kobayashi S; Sakaguchi K; Sugawara F
    Bioconjug Chem; 2008 Dec; 19(12):2417-26. PubMed ID: 19035789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of affinity ligands and relation of their structure with adsorption of proteins.
    Ye L; Xu A; Cheng C; Zhang L; Huo C; Huang F; Xu H; Li R
    J Sep Sci; 2011 Nov; 34(22):3145-50. PubMed ID: 22015803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic affinity ligands as a novel tool to improve protein stability.
    Sousa IT; Ruiu L; Lowe CR; Taipa MA
    J Mol Recognit; 2009; 22(2):83-90. PubMed ID: 18654989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase].
    Tanaka A
    Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1786-7. PubMed ID: 18051426
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficient purification of recombinant proteins fused to maltose-binding protein by mixed-mode chromatography.
    Cabanne C; Pezzini J; Joucla G; Hocquellet A; Barbot C; Garbay B; Santarelli X
    J Chromatogr A; 2009 May; 1216(20):4451-6. PubMed ID: 19329121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of FKBP-related proteins with antibodies of predetermined specificity and isolation by FK 506 affinity chromatography.
    Rosborough SL; Fleming M; Nelson PA; Boger J; Harding MW
    Transplant Proc; 1991 Dec; 23(6):2890-3. PubMed ID: 1721306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.